COLOMBO, Sri Lanka — Sri Lanka received 600,000 doses of the Sinopharm vaccine from China as a donation on Wednesday.
Sri Lankan authorities said the supplied doses will go first to Chinese citizens in Sri Lanka, where thousands of people from China are working.
Sri Lankan President Gotabaya Rajapaksa accepted the vaccine from Chinese Ambassador Qi Zhenhong at the airport after the doses were flown in on Wednesday.
Sri Lankan officials have said the vaccine will be given to Sri Lankans only after the island nation receives clearance from the World Health Organization.
Sinopharm is the third vaccine to be approved in Sri Lanka and the second the country has obtained in it’s fight against COVID-19.
Sri Lanka has so far used Oxford-AstraZeneca shots to vaccinate more than 903,000 people. The government also has arranged to buy 7 million doses of the Russian-developed vaccine Sputnik V.
GENEVA (AP) — The World Health Organization said Friday that COVID-19 no longer qualifies as a global emergency, marking a symbolic end to the devastating coronavirus pandemic that triggered once-unthinkable lockdowns, upended economies and killed millions of people worldwide.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.07 USD
